Your best medicine news resource
Apr 22nd 2008Drug InformationAbortion
The Missouri House on Tuesday voted 108-33 to preliminarily approve a bill (HB 1831) that includes multiple restrictions on abortion rights, the AP/St. Louis Post-Dispatch reports.
More: continued here
Apr 22nd 2008Drug InformationAbortion
The Tennessee Senate Judiciary Committee on Thursday voted 5-3 to send a bill (SB 3512) that would require a 24-hour waiting period prior to abortions and require physicians to obtain “informed consent” to a committee that will study it this summer, the AP/Jackson Sun reports.
More: continued here
Apr 22nd 2008Drug InformationAlzheimer's / Dementia News XML/RSS Feed
For the first time, new research demonstrates that curbing harmful antioxidant processes in the brain’s vasculature can reverse some of the cognitive decline associated with Alzheimer’s disease. A natural enzyme of the immune system — NADPH oxidase — has been found to have toxic side effects, producing free radicals in the brains of mice.
More: continued here
Apr 22nd 2008Drug InformationAlzheimer's / Dementia News XML/RSS Feed
Medivation, Inc. (NASDAQ: MDVN) has announced that Alzheimer’s patients treated with the investigational drug Dimebon? showed improvement in the key aspects of cognitive function over a one-year period compared with placebo. The improvement occurred in not only memory and language, but also in more complex functions such as awareness of time and place, and praxis - the process of getting an idea and initiating and completing a new motor task.
More: continued here
Apr 22nd 2008Drug InformationAlcohol / Addiction / Illegal Drugs
Raptor Pharmaceuticals Corp. (”Raptor” or the “Company”) (OTC Bulletin Board: RPTP), announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. (”Bennu”), has initiated the Company’s first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole (”4-MP”) in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia(TM) program.
More: continued here
Apr 22nd 2008Drug InformationArthritis
Australia’s adult stem cell company, Mesoblast Limited (ASX: MSB; USOTC: MBLTY), announced successful long-term results in its osteoarthritis preclinical trials. A single injection of its proprietary allogeneic, or “off-the-shelf”, adult stem cells into arthritic knees provided sustained protection against cartilage destruction and degeneration for up to nine months.
More: continued here
Apr 22nd 2008Drug InformationArthritis
Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) announced that its collaboration partner Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), has initiated a Phase 1 clinical trial of SBI-087, a next-generation drug candidate for the treatment of rheumatoid arthritis (RA). In collaboration with Trubion, Wyeth Pharmaceuticals is developing SBI-087 and other CD20-directed products.
More: continued here
Apr 22nd 2008Drug InformationAlzheimer's / Dementia News XML/RSS Feed
Today’s Ministerial statement on dementia by Shona Robison MSP is warmly welcomed by Alzheimer Scotland. It confirms that the Scottish Government recognises the scale of the problem of dementia in Scotland, as highlighted by our recent report The Dementia Epidemic - where Scotland is now and the challenge ahead.
More: continued here
Apr 22nd 2008Drug InformationADHD
The use of the medication methylphenidate considerably improves the driving ability of people with ADHD. This was shown in research done by Joris Verster of Utrecht University, The Netherlands. The study will appear in the May 2008 issue of Journal of Psychopharmacology.People with ADHD are often prescribed methylphenidate (brand name Ritalin) to counteract hyperactive behavior and attention dysfunction that may negatively affect their driving ability.
More: continued here
Apr 22nd 2008Drug InformationAlcohol / Addiction / Illegal Drugs
New drug research suggests that teens may get addicted and relapse more easily than adults because developing brains are more powerfully motivated by drug-related cues. This conclusion has been reached by researchers who found that adolescent rats given cocaine - a powerfully addicting stimulant - were more likely than adults to prefer the place where they got it.
More: continued here
Your best medicine news resource
